PharmaDiagnostics develops label-free screening technology without the need for specialized hardware. The technology is broadly enabling and applicable to a range of applications: receptor-ligand binding, enzymatic reactions, antibody screening and ADME. The assays are sensitive and have the potential for very high throughput. The technology platform is based on localized surface plasmon resonance (LSPR) and noble metal nanoparticles, and is run on standard laboratory equipment.
